W. Krawietz
About
In The Last Decade
W. Krawietz
37 papers receiving 679 citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 412
- Inorganic Chemistry 290
- Physiology 171
- Cardiology and Cardiovascular Medicine 148
- Nutrition and Dietetics 98
Countries citing papers authored by W. Krawietz
This map shows the geographic impact of W. Krawietz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Krawietz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Krawietz more than expected).
Fields of papers citing papers by W. Krawietz
This network shows the impact of papers produced by W. Krawietz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Krawietz. The network helps show where W. Krawietz may publish in the future.
Co-authorship network of co-authors of W. Krawietz
This figure shows the co-authorship network connecting the top 25 collaborators of W. Krawietz. A scholar is included among the top collaborators of W. Krawietz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Krawietz. W. Krawietz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | 7 | |
| 3 | 33 | |
| 4 | 5 | |
| 5 | [Hypereosinophilia with endomyocardial fibrosis and non-Hodgkin lymphoma (chronic lymphatic type B leukemia) in a 48-year-old patient]. | 0 |
| 6 | 28 | |
| 7 | [Scleredema adultorum Buschke and primary biliary cirrhosis in a 58-year-old patient]. | 3 |
| 8 | 23 | |
| 9 | 33 | |
| 10 | 32 | |
| 11 | 27 | |
| 12 | 4 | |
| 13 | 7 | |
| 14 | 10 | |
| 15 | 8 | |
| 16 | 36 | |
| 17 | 58 | |
| 18 | 4 | |
| 19 | [Significance of serum digoxin concentration and its influencing factors]. | 1 |
| 20 | [Experimental and clinical findings on treatment of cardiac-glucoside intoxication]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.